164 related articles for article (PubMed ID: 16961036)
1. A new way to deliver psychiatric meds.
Levin-Epstein M
Behav Healthc; 2006 Aug; 26(8):22-3. PubMed ID: 16961036
[No Abstract] [Full Text] [Related]
2. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
3. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
4. Methylphenidate transdermal system.
Mays DA; Findling R
J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
[No Abstract] [Full Text] [Related]
5. Medication for children with attention disorders.
Kash IJ
Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9164792
[No Abstract] [Full Text] [Related]
6. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
Biederman J
J Clin Psychiatry; 2006; 67 Suppl 8():4-6. PubMed ID: 16961423
[No Abstract] [Full Text] [Related]
7. Transdermal methylphenidate system: old wine in a new bottle.
Bukstein OG
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
[TBL] [Abstract][Full Text] [Related]
8. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
Mott TF; Leach L; Johnson L
J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
[No Abstract] [Full Text] [Related]
9. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
10. Quillivant XR--an extended release oral suspension of methylphenidate.
Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
[No Abstract] [Full Text] [Related]
11. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
12. Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
Thase ME
J Clin Psychiatry; 2006 Apr; 67(4):671-2. PubMed ID: 16669733
[No Abstract] [Full Text] [Related]
13. Attention-deficit-hyperactivity disorder.
Diller LH
N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
[No Abstract] [Full Text] [Related]
14. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
Silva RR
Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
[No Abstract] [Full Text] [Related]
15. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
16. No news is bad news?
J Psychosoc Nurs Ment Health Serv; 1999 Apr; 37(4):15. PubMed ID: 10218185
[No Abstract] [Full Text] [Related]
17. Flawed attention-deficit/hyperactivity disorder medication comparison.
Adesman A
Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
[No Abstract] [Full Text] [Related]
18. Need for bedtime dose of ritalin.
Rogers WB
Pediatrics; 1996 Aug; 98(2 Pt 1):314. PubMed ID: 8692642
[No Abstract] [Full Text] [Related]
19. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
[TBL] [Abstract][Full Text] [Related]
20. [Central nervous system stimulants in AD/HD in adults].
Aanonsen NO; Lensing MB; Mathiesen T
Tidsskr Nor Laegeforen; 1999 Jan; 119(1):82-3. PubMed ID: 10025211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
